ANLVSBTAI• 6 Months (Normalized)
ANL vs BTAI (Adlai Nortye Group Ltd. vs BioXcel Therapeutics Inc.)
Showing Closing Date Range from Mar 29 to Sep 25, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ANL Performance $15.83
+139.49%
Adlai Nortye Group Ltd.
Normalized Baseline0.00%
BTAI Performance $0.04
-97.08%
BioXcel Therapeutics Inc.
Normalized Baseline0.00%
Alpha Spread Margin ANL LEADS
+236.57 pts
ANL outperforming by 236.57 percentage points
ANLBTAI
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ANL BTAI
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(124 dates)
| Date | ANL Price | ANL Gain (%) | BTAI Price | BTAI Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 24, 2026 | $15.83 | +139.49% | $0.04 | -97.08% | +236.57% |
| Sep 23, 2026 | $15.75 | +138.28% | $0.05 | -96.28% | +234.56% |
| Sep 22, 2026 | $16.60 | +151.13% | $0.04 | -96.31% | +247.44% |
| Sep 21, 2026 | $15.57 | +135.55% | $0.06 | -94.92% | +230.47% |
| Sep 18, 2026 | $15.74 | +138.12% | $0.06 | -95.21% | +233.33% |
| Sep 17, 2026 | $15.28 | +131.16% | $0.08 | -93.79% | +224.95% |
| Sep 16, 2026 | $15.52 | +134.80% | $0.07 | -94.47% | +229.27% |
| Sep 15, 2026 | $15.00 | +126.93% | $0.04 | -96.31% | +223.24% |
| Sep 14, 2026 | $15.93 | +141.00% | $0.05 | -96.27% | +237.27% |
| Sep 11, 2026 | $15.21 | +130.11% | $0.05 | -95.79% | +225.90% |
| Sep 10, 2026 | $15.09 | +128.29% | $0.05 | -95.87% | +224.16% |
| Sep 09, 2026 | $14.70 | +122.31% | $0.05 | -96.12% | +218.43% |
| Sep 08, 2026 | $15.51 | +134.64% | $0.04 | -96.45% | +231.09% |
| Sep 04, 2026 | $15.01 | +127.08% | $0.07 | -93.89% | +220.97% |
| Sep 03, 2026 | $14.75 | +123.15% | $0.12 | -90.25% | +213.40% |
Page 1 of 9